2st DIP Asia-Pacific (DIPAP) Symposium on Diabetes, Hypertension, Metabolic Syndrome and Pregnancy 2017 Shanghai

  • Conference Call
  • It is with great plea­sure to announce and to invite you to join us at The 2nd Asia Pacific Sym­po­sium on Dia­betes, Hyper­ten­sion, Meta­bolic Syn­drome and Preg­nancy (DIPAP) Greater China to take place this com­ing Octo­ber 2728, 2017 in Shang­hai, China at the Jing An Shangri La West Shang­hai.

    The Sym­po­sium is held in order to high­light and doc­u­ment sci­en­tif­i­cally and prac­ti­cally on how to pre­vent, diag­nose and man­age HIP to opti­mize care and out­comes in what is seen as a large knowl­edge gap within the field. The great suc­cess of the pre­vi­ous Ten DIP Sym­posia held all over Europe and the first in Asia-​Pacific in 2016 have paved the way for the Inau­gural DIPAP Greater China Sym­po­sium. Like the DIP Sym­po­sium in Europe, Greater China will aim to raise aware­ness of the con­nec­tion between hyper­glycemia and poor preg­nancy out­comes, where there needs to be a greater global focus on pre­vent­ing, screen­ing, diag­nos­ing, and man­ag­ing hyper­glycemia in pregnancy.

    The DIP Sym­po­sium con­tin­u­ously aims to lead a greater global focus on Hyper­ten­sion in Preg­nancy (HIP), mater­nal and fetal med­i­cine. Doing so by rais­ing aware­ness of the links between hyper­glycemia and poor mater­nal and fetal out­comes as well as to the future health risks to mother and off­spring and demand a clearly defined global health agenda to tackle this issue. To pro­vide guid­ance for test­ing, man­age­ment and care of women with HIP regard­less of resource set­ting as out­lined in the FIGO doc­u­ment and to inspire action by show­cas­ing ongo­ing ini­tia­tives on dia­betes in preg­nancy in the region and globally.

    The DIPAP Greater China Sym­po­sium will intro­duce a unique pro­gram on “Dig­i­tal Health” whereby start-​up com­pa­nies, inno­v­a­tive con­cepts, devel­op­ment of ideas to exe­cu­tion will be brought to the fore­front in keynote lec­tures and demon­stra­tions. A never-​before col­lab­o­ra­tion of Sci­en­tific con­tent and hi-​tech will meet, lis­ten and dis­cuss on the third day of the Sym­po­sium. The Dig­i­tal Health pro­gram will suc­cess­fully address and high­light the impor­tance of intro­duc­ing and includ­ing dig­i­tal health within the treat­ment of Dia­betes, Hyper­ten­sion, Meta­bolic Syn­drome and Pregnancy.

    Des­ig­nated sci­en­tific ses­sions spe­cific to HIP and the spe­cific region is set out to pro­vide in great detail the impor­tance of HIP locally and region­ally. It is impor­tant for such a course to take place in order to allow par­tic­i­pants to receive a great overview of mat­ters con­cern­ing their geo­graph­i­cal region within a short time frame. The pro­gram pro­vides a spe­cific and tar­geted overview from cer­tain mat­ters of the over­all Sym­po­sium, allow­ing it to reach its tar­geted audi­ence and ide­ally reach max­i­mum impact in teach­ing /​bring­ing to light the mat­ters sur­round­ing HIP.

    Addi­tion­ally, con­tro­ver­sial top­ics and use of new tech­nolo­gies in peri­na­tal med­i­cine will be dis­cussed in detail. This will allow par­tic­i­pants to for­mu­late a modus operandi through evi­dence pro­vided by the pre­sent­ing experts. Inno­va­tions con­nected to peri­na­tal research on Whole Genome Sequenc­ing, NIPT, small RNA’s, Metabolomics and Micro­biota will be dis­cussed at length at the Sym­po­sium. The fac­ulty com­prises of renowned pro­fes­sion­als and prac­ti­tion­ers from all over the world, who will present the most updated clin­i­cal and lab­o­ra­tory rev­o­lu­tions, based on evi­dence as well as prac­ti­cal experience.

    Con­firmed Speakers

    • Luis Cabero Roura, Spain
    • Hema Divakar, India (FIGO WG)
    • Tony Duan, China
    • Moshe Hod, Israel
    • Anil Kapur, India
    • Ji Linong, China
    • Ronald Ma, Hong Kong
    • Tahir Mah­mood, UK
    • Naren­dra Mal­horta, India
    • Guang Ning, China
    • CN Puran­dare, India, FIGO President
    • Rina Su, China
    • Ger­ard Visser, Netherlands
    • Huixia Yang, China (FIGO WG)
    • Yariv Yogev, Israel
    • Luy­ing Zhang, China

    Sym­po­sium Topics

    • Non Com­mu­ni­ca­ble Dis­ease & Preg­nancy global epi­demic — It’s all about the mother and the offspring
    • Non Com­mu­ni­ca­ble Dis­ease & Preg­nancy – The FIGO Global vision
    • IDF Global Vision: Dia­betes in Pregnancy
    • Mater­nal Health – The Impact of Dia­betes, Obe­sity, Hyper­ten­sion in Pregnancy
    • Mother with Preg­nancy Induced Com­pli­ca­tions – How do we Improve Outcome?
    • The Fetus — Is There an Opti­mal Birth Weight?
    • The Fetus — Pre­ven­tion of Preterm Birth: Towards Healthy Moth­ers and Healthy Babies
    • Ren­o­vat­ing Mater­nal Fetal Medicine
    • Mater­nal Fetal Med­i­cine — The Great Obstet­ri­cal Syn­dromes; from basics to mol­e­c­u­lar biology
    • Fetal Med­i­cine — Inno­va­tions in pre­dic­tion and prevention
    • New tech­nolo­gies in dia­betic pregnancy
    • Pla­cen­tal insuf­fi­ciency: preeclamp­sia and fetal growth
    • Patho­gen­e­sis of preeclamp­sia: Clues to pre­ven­tion and treatment
    • Preeclamp­sia: iden­ti­fi­ca­tion of pre-​clinical dis­ease and man­age­ment issues
    • Early pre­dic­tion and pre­ven­tion of IUGR
    • IUGR and SGA: Doppler man­age­ment and pre­dic­tion of out­comeObe­sity or Meta­bolic Syn­drome in Preg­nancy, which is more haz­ardous to the mother and offspring?
    • Peri­na­tal pro­gram­ming of obesity
    • Pre-​pregnancy man­age­ment of the obese patient
    • Health sys­tem and soci­etal bar­ri­ers in improv­ing dia­betes related mater­nal health
    • Towards a Con­sen­sus; The FIGO-​GDM Ini­tia­tive Project
    • The Asia Pacific Expe­ri­ence: Learn­ing from the SAIDIP & Greater China experience
    • Tribu­la­tions and tri­umphs in imple­ment­ing a national strat­egy for GDM screen­ing diag­no­sis and care in India
    • Analy­sis of the cost-​effectiveness of car­ry­ing out GDM screen­ing in India
    • Ges­ta­tional dia­betes mel­li­tus in China: Dif­fi­cul­ties and cop­ing strategies
    • Analy­sis of the cost-​effectiveness of car­ry­ing out GDM screen­ing in China
    • State of the art on insulin ana­logues and pregnancy
    • Dif­fer­ences between early and late onset pla­cen­tal dis­ease — impli­ca­tions for screening
    • Aspects of preeclamp­sia risk cal­cu­la­tion: Pop­u­la­tions and individuals
    • First-​trimester mater­nal risk assess­ment — A health eco­nomic perspective
    • Crit­i­cal eval­u­a­tion of poten­tial treat­ments: The case for/​against aspirin
    • Towards a solu­tion — The ASPRE Study
    • Nutri­tional fac­tors and sup­ple­men­ta­tion on mater­nal and infant outcome
    • Diet and preg­nancy out­comes– exam­ples based on the role of micronu­tri­ents and macronuri­ents in the devel­op­ment of ges­ta­tional diabetes
    • Nutri­tional sup­ple­men­ta­tion and the pre­ven­tion of fetal con­gen­i­tal abnormalitie
    • Dif­fer­ences in growth tra­jec­to­ries between infants of women with type-​1 and type-​2 diabetes?

    CME Accreditation

    Euro­pean Accred­i­ta­tion Coun­cil for Con­tin­u­ing Med­ical Edu­ca­tion (UEMS/​EACCME)

    An appli­ca­tion will be made to the Euro­pean Accred­i­ta­tion Coun­cil for Con­tin­u­ing Med­ical Edu­ca­tion (EAC­CME) for CME accred­i­ta­tion of this event. The EAC­CME is an insti­tu­tion of the Euro­pean​Union of Med­ical Spe­cial­ists (UEMS).

    Amer­i­can Med­ical Asso­ci­a­tion (AMA)

    Through an agree­ment between the Euro­pean Union of Med­ical Spe­cial­ists and the Amer­i­can Med­ical Asso­ci­a­tion, physi­cians may con­vert EAC­CME cred­its to an equiv­a­lent num­ber of AMA PRA Cat­e­gory 1 Cred­its™.

    Royal Col­lege of Physi­cians and Sur­geons of Canada

    Live edu­ca­tional activ­i­ties, occur­ring out­side of Canada, rec­og­nized by the UEMS-​EACCME for ECMEC cred­its are deemed to be Accred­ited Group Learn­ing Activ­i­ties (Sec­tion 1) as defined by the Main­te­nance of Cer­ti­fi­ca­tion Pro­gram of The Royal Col­lege of Physi­cians and Sur­geons of Canada.

    Organisers

    Sym­po­sium Presidents

    • Moshe Hod, Israel and Gian Carlo Di Renzo, Italy
    • Gian Paolo Donzelli, Italy
    • Tony Duan, China
    • TY Leung, Hong Kong
    • Ji Linong, China, IDF
    • Guang Ning, China
    • Liona Poon, Hong Kong
    • George SH Yeo, Singapore
    starting: ending: 29.10.2017 Location: , Category:

    Timeline

    Conference START 29.10.2017 END

    All deadlines have expired!

    This conference has no more open deadlines. There may be successive conferences coming up you may by interested in.

    Please check our conference list and search...

    Conference Facts

    Location , Address Yan'an Middle Road 1218 Category Organiser More Info Conference Website

    Further interesting Conferences

    discover MORE CONFERENCES